Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
C. indicum improved loss of body weight, impaired glucose tolerance, and inhibited muscle protein degradation factors MAFbx and MuRF1 in mice [PMID:39624846].
A 0.5% water extract cosmetic cream was evaluated in human volunteers; extracts dose-dependently inhibited mushroom tyrosinase activity [PMID:26786567].
C. indicum was identified as having high xanthine oxidase inhibitory activity (>85%) [PMID:29628890].
Linarin, a principal constituent, attenuated hyperuricemic nephropathy in mouse models [PMID:39908585].
Dimeric guaianolide sesquiterpenoids from the flowers ameliorate hepatic steatosis by mitigating SIRT1-mediated lipid accumulation and ferroptosis [PMID:39788286].
Synthèse des preuves
Sources PubMed
- 1.PMID: 38009816 (2024) — Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation. · Journal of cachexia, sarcopenia and muscle
- 2.PMID: 39788286 (2025) — Dimeric guaianolide sesquiterpenoids from the flowers of Chrysanthemum indicum ameliorate hepatic steatosis through mitigating SIRT1-mediated lipid accumulation and ferroptosis. · Journal of advanced research
- 3.PMID: 39908585 (2025) — Linarin attenuates hyperuricemic nephropathy by modulating Nrf2/Keap1 and TLR4/NF-κB signaling pathways: Linarin attenuates hyperuricemic nephropathy. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 4.PMID: 39624846 (2024) — Chrysanthemum indicum L. ameliorates muscle atrophy by improving glucose tolerance in CT26-induced cancer cachexia. · Frontiers in pharmacology
- 5.PMID: 29628890